EMZF-1--A NOVEL GENE REQUIRED FOR EMBRYONIC HEMATOPOIESIS

EMZF-1--胚胎造血所需的新基因

基本信息

  • 批准号:
    6101895
  • 负责人:
  • 金额:
    $ 29.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-06-01 至 2001-05-31
  • 项目状态:
    已结题

项目摘要

The hematopoietic system in mammals is composed of diverse cell types that perform distinct and specialized functions. These terminally differentiated cells are short-lived, formed from a pool of totipotent hematopoietic stem cells (HSC) whose presumptive origin is the mesodermal cells of the yolk sac blood islands. Although progress has been made in the identification of HSC activity from the adult bone marrow, no such homogeneous cell population has been identified, and no genetic markers exist to identify such cells. We hypothesize that transcripts unique to the earliest HSC will provide genetic lineage markers enabling us to trace and manipulate the development of the primordial HSC. Using a molecular genetic approach we have recently identified a novel cDNA clone from a 9.5 day blood island/yolk sac cDNA library using the human myeloid zinc finger (MZF)-1 cDNAproble. This newly identified cDNA clone, extraembryonic mesoderm zinc finger-1 (EM ZF-1), was shown to be expressed exclusively in the extraembryonic mesoderm of the yolk sac, ina the fetal liver and heart of developing embryos and in the bone marrow, spleen and thymus of adult mice suggesting a role in mammalian hematopoiesis. This gene is located on mouse chromosome 5 and contains 12 C2H2 Kruppel-like zinc finger motifs in two separate regions which are highly homologous to several of the finger domains in MZF-1. EMZF-1 also contains an alanine/arginine-rich region downstream from the zinc finger motif. Such a domain has been found in other zinc finger genes and appears to be important for transcriptional regulation. The EMZF-1 gene maps to human chromosome 7 in an area associated with myeloid and lymphoid leukemias. Interestingly, PLZF, a newly discovered gene identified as a fusion partner with retinoid acid receptor-alpha in a variant t (11;17) translocation associated with acute promyelocytic leukemia, is also homologous to EMZF-1. Thus, EMZF-1 is the third member of a newly formed hematopoietic-specific zinc finger gene family whose function appears to be in the control of hematopoietic differentiation. The functional requirement for the EMZF-1 gene product appears early in mouse development since antisense oligonucleotides specific for EMZF-1 abrogates hematopoiesis in 14.5 day fetal liver and adult bone marrow cultures in vitro. Finally, another cDNA clone demonstrating high cross reactivity to the EMZF-1 was identified. This clone, LM-1D has been partially sequenced and determined to be an independent cDNA. We propose to characterize the lineage-specific expression of EMZF-1, identify its genomic structure and promoter elements and to begin the analysis of its function in vivo. The potential of EMZF-1 and the highly related LM-1D clone as molecular markers of primordial HSCs will be explored in vitro and in vivo and their function in hematopoiesis and leukemigenesis elucidated.
哺乳动物的造血系统由不同类型的细胞组成

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAY L ROTHSTEIN其他文献

JAY L ROTHSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAY L ROTHSTEIN', 18)}}的其他基金

Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
皮质类固醇的免疫细胞靶向改变了严重慢性炎症性疾病的治疗
  • 批准号:
    10435587
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
皮质类固醇的免疫细胞靶向改变了严重慢性炎症性疾病的治疗
  • 批准号:
    10324755
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
皮质类固醇的免疫细胞靶向改变了严重慢性炎症性疾病的治疗
  • 批准号:
    10625527
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
Targeting leukocyte metabolism to treat human autoimmune disease
靶向白细胞代谢治疗人类自身免疫性疾病
  • 批准号:
    9763441
  • 财政年份:
    2018
  • 资助金额:
    $ 29.02万
  • 项目类别:
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
靶向检查点调节因子 VISTA 治疗炎症性疾病
  • 批准号:
    9255938
  • 财政年份:
    2017
  • 资助金额:
    $ 29.02万
  • 项目类别:
Targeting the checkpoint regulator VISTA for treatment of inflammatory disease
靶向检查点调节因子 VISTA 治疗炎症性疾病
  • 批准号:
    9752441
  • 财政年份:
    2017
  • 资助金额:
    $ 29.02万
  • 项目类别:
Safe and effective anti CD154 antibodies for therapeutic intervention
用于治疗干预的安全有效的抗 CD154 抗体
  • 批准号:
    9202640
  • 财政年份:
    2012
  • 资助金额:
    $ 29.02万
  • 项目类别:
Safe and effective anti CD154 antibodies for therapeutic intervention
用于治疗干预的安全有效的抗 CD154 抗体
  • 批准号:
    9271146
  • 财政年份:
    2012
  • 资助金额:
    $ 29.02万
  • 项目类别:
Role of Tcl-1 in Lymphoid Development
Tcl-1 在淋巴发育中的作用
  • 批准号:
    6340778
  • 财政年份:
    2000
  • 资助金额:
    $ 29.02万
  • 项目类别:
Role of Tcl-1 in Lymphoid Development
Tcl-1 在淋巴发育中的作用
  • 批准号:
    6232701
  • 财政年份:
    1999
  • 资助金额:
    $ 29.02万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 29.02万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了